Literature DB >> 20659385

Implanon failure in patients on antiretroviral medication: the importance of disclosure.

Nisha Lakhi, Abha Govind.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20659385     DOI： 10.1783/147118910791749164

Source DB:  PubMed          Journal:  J Fam Plann Reprod Health Care        ISSN： 1471-1893


× No keyword cloud information.
  10 in total

1.  Efavirenz decreases etonogestrel exposure: a pharmacokinetic evaluation of implantable contraception with antiretroviral therapy.

Authors:  Catherine A Chappell; Mohammed Lamorde; Shadia Nakalema; Beatrice A Chen; Hope Mackline; Sharon A Riddler; Susan E Cohn; Kristin M Darin; Sharon L Achilles; Kimberly K Scarsi
Journal:  AIDS       Date:  2017-09-10       Impact factor: 4.177

2.  Important Drug-Drug Interactions in HIV-Infected Persons on Antiretroviral Therapy: An Update on New Interactions Between HIV and Non-HIV Drugs.

Authors:  Alice Tseng; Michelle Foisy
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

Review 3.  Effects of hormonal contraception on antiretroviral drug metabolism, pharmacokinetics and pharmacodynamics.

Authors:  Andrea R Thurman; Sharon Anderson; Gustavo F Doncel
Journal:  Am J Reprod Immunol       Date:  2014-02-13       Impact factor: 3.886

Review 4.  Beyond the Pap Smear: Gender-responsive HIV Care for Women.

Authors:  Jaimie P Meyer; Julie A Womack; Britton Gibson
Journal:  Yale J Biol Med       Date:  2016-06-27

Review 5.  Concomitant contraceptive implant and efavirenz use in women living with HIV: perspectives on current evidence and policy implications for family planning and HIV treatment guidelines.

Authors:  Rena C Patel; Chelsea Morroni; Kimberly K Scarsi; Tabitha Sripipatana; James Kiarie; Craig R Cohen
Journal:  J Int AIDS Soc       Date:  2017-05-11       Impact factor: 5.396

6.  Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: A Systematic review.

Authors:  Julie A Womack; Gina Novick; Joseph L Goulet
Journal:  Open Access J Contracept       Date:  2015-05-07

7.  Contraceptive implant failures among women using antiretroviral therapy in western Kenya: a retrospective cohort study.

Authors:  Anne Pfitzer; Jacqueline Wille; Jonesmus Wambua; Stacie C Stender; Molly Strachan; Christine Maricha Ayuyo; Timothy F Kibidi Muhavi; Valentino Wabwile; Supriya D Mehta; Elizabeth Sasser
Journal:  Gates Open Res       Date:  2019-06-04

Review 8.  Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy.

Authors:  Jennifer A Robinson; Roxanne Jamshidi; Anne E Burke
Journal:  Infect Dis Obstet Gynecol       Date:  2012-08-14

Review 9.  Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.

Authors:  Rena C Patel; Maricianah Onono; Monica Gandhi; Cinthia Blat; Jill Hagey; Starley B Shade; Eric Vittinghoff; Elizabeth A Bukusi; Sara J Newmann; Craig R Cohen
Journal:  Lancet HIV       Date:  2015-10-22       Impact factor: 12.767

10.  Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.

Authors:  Kimberly K Scarsi; Kristin M Darin; Shadia Nakalema; David J Back; Pauline Byakika-Kibwika; Laura J Else; Sujan Dilly Penchala; Allan Buzibye; Susan E Cohn; Concepta Merry; Mohammed Lamorde
Journal:  Clin Infect Dis       Date:  2015-12-08       Impact factor: 9.079
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.